Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2016

Open Access 01-12-2016 | Research article

Adding non-randomised studies to a Cochrane review brings complementary information for healthcare stakeholders: an augmented systematic review and meta-analysis

Authors: Chantal Arditi, Bernard Burnand, Isabelle Peytremann-Bridevaux

Published in: BMC Health Services Research | Issue 1/2016

Login to get access

Abstract

Background

To reduce the burden of asthma, chronic disease management (CDM) programmes have been widely implemented and evaluated. Reviews including randomised controlled trials (RCTs) suggest that CDM programmes for asthma are effective. Other study designs are however often used for pragmatic reasons, but excluded from these reviews because of their design. We aimed to examine what complementary information could be retrieved from the addition of non-randomised studies to the studies included in a published Cochrane review on asthma CDM programmes, for healthcare stakeholders involved in the development, implementation, conduct or long-term sustainability of such programmes.

Methods

Extending a previously published Cochrane review, we performed a systematic review (augmented review) including any type of study designs instead of only those initially accepted by Cochrane and the Effective Practice and Organization of Care Review group. After double data selection and extraction, we compared study and intervention characteristics, assessed methodological quality and ran meta-analyses, by study design.

Results

We added 37 studies to the 20 studies included in the Cochrane review. The applicability of results was increased because of the larger variety of settings and asthma population considered. Also, adding non-randomised studies provided new evidence of improvements associated with CDM intervention (i.e. healthcare utilisation, days off work, use of action plan). Finally, evidence of CDM effectiveness in the added studies was consistent with the Cochrane review in terms of direction of effects.

Conclusions

The evidence of this augmented review is applicable to a broader set of patients and settings than those in the original Cochrane review. It also strengthens the message that CDM programmes have a beneficial effect on quality of life and disease severity, meaningful outcomes for the everyday life of patients with asthma. Despite the moderate to low methodological quality of all studies included, calling for caution in results interpretation and improvements in CDM evaluation methods and reporting, the inclusion of a broader set of study designs in systematic reviews of complex interventions, such as chronic disease management, is likely to be of high value and interest to patients, policymakers and other healthcare stakeholders.
Appendix
Available only for authorised users
Literature
1.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.PubMed
2.
Levy BD, Noel PJ, Freemer MM, Cloutier MM, Georas SN, Jarjour NN, et al. Future research directions in asthma: An NHLBI Working Group Report. Am J Respir Crit Care Med. 2015. doi:10.​1164/​rccm.​201505-0963WS.
3.
To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204.PubMedPubMedCentral
4.
Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–96.PubMed
5.
6.
Lemmens KM, Nieboer AP, van Schayck CP, Asin JD, Huijsman R. A model to evaluate quality and effectiveness of disease management. Qual Saf Health Care. 2008;17(6):447–53.PubMed
7.
Faxon DP, Schwamm LH, Pasternak RC, Peterson ED, McNeil BJ, Bufalino V, et al. Improving quality of care through disease management: principles and recommendations from the American Heart Association’s Expert Panel on Disease Management. Circulation. 2004;109(21):2651–4.PubMed
8.
Krumholz HM, Currie PM, Riegel B, Phillips CO, Peterson ED, Smith R, et al. A taxonomy for disease management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing Group. Circulation. 2006;114(13):1432–45.PubMed
9.
10.
Epping-Jordan JE, Pruitt SD, Bengoa R, Wagner EH. Improving the quality of health care for chronic conditions. Qual Saf Health Care. 2004;13(4):299–305.PubMedPubMedCentral
11.
Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001;20(6):64–78.
12.
13.
Bravata DM, McDonald KM, Shojania KG, Sundaram V, Owens DK. Challenges in systematic reviews: synthesis of topics related to the delivery, organization, and financing of health care. Ann Intern Med. 2005;142(12 Pt 2):1056–65.PubMed
14.
Deeks JJ, Dinnes J, D’Amico R, Sowden AJ, Sakarovitch C, Song F, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7(27):iii–x. 1-173.PubMed
15.
Davidoff F, Batalden P, Stevens D, Ogrinc G, Mooney S, Group SD. Publication guidelines for improvement studies in health care: evolution of the SQUIRE project. Ann Intern Med. 2008;149(9):670–6.PubMed
16.
17.
Tinetti ME, Studenski SA. Comparative effectiveness research and patients with multiple chronic conditions. N Engl J Med. 2011;364(26):2478–81.PubMed
18.
Norris SL, Atkins D. Challenges in using nonrandomized studies in systematic reviews of treatment interventions. Ann Intern Med. 2005;142(12_Part_2):1112–9.PubMed
19.
20.
21.
22.
23.
Sterne JAC, Higgins JPT, Reeves BC on behalf of the development group for ACROBAT-NRSI. A Cochrane Risk Of Bias Assessment Tool: for Non-Randomized Studies of Interventions (ACROBAT-NRSI), Version 1.0.0. 24 Sept 2014. www.​riskofbias.​info. Accessed 23 Sept 2015.
24.
Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377–84.PubMedPubMedCentral
25.
Thomas BH, Ciliska D, Dobbins M, Micucci S. A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews Evid Based Nurs. 2004;1(3):176–84.PubMed
26.
Armijo-Olivo S, Stiles CR, Hagen NA, Biondo PD, Cummings GG. Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research. J Eval Clin Pract. 2012;18(1):12–8.PubMed
27.
Valentine JC, Thompson SG. Issues relating to confounding and meta-analysis when including non-randomized studies in systematic reviews on the effects of interventions. Res Synth Methods. 2013;4(1):26–35.PubMed
28.
Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011. http://​handbook.​cochrane.​org. Accessed 24 July 2015.
29.
30.
31.
Allen-Ramey FC, Diette GB, McDonald RC, Skinner EA, Steinwachs DM, Wu AW. Methods aimed at improving asthma care and outcomes management: a case study. Dis Manag Health Out. 2002;10(8):495–503.
32.
Curtin K, Hayes BD, Holland CL, Katz LA. Computer-generated intervention for asthma population care management. Eff Clin Pract. 1998;1(1):43–6.PubMed
33.
Gaude GS, Hattiholi J, Chaudhury A. Role of health education and self-action plan in improving the drug compliance in bronchial asthma. J Fam Med Prim Care. 2014;3(1):33–8.
34.
Kelso TM, Abou-Shala N, Heilker GM, Arheart KL, Portner TS, Self TH. Comprehensive long-term management program for asthma: effect on outcomes in adult African-Americans. Am J Med Sci. 1996;311(6):272–80.PubMed
35.
Saini B, Filipovska J, Bosnic-Anticevich S, Taylor S, Krass I, Armour C. An evaluation of a community pharmacy-based rural asthma management service. Aust J Rural Health. 2008;16(2):100–8.PubMed
36.
Saini B, Krass I, Armour C. Development, implementation, and evaluation of a community pharmacy-based asthma care model. Ann Pharmacother. 2004;38(11):1954–60.PubMed
37.
Tatis V, Remache D, DiMango E. Results of a culturally directed asthma intervention program in an inner-city Latino community. Chest. 2005;128(3):1163–7.PubMed
38.
Brandao HV, Cruz CM, Santos Ida Jr S, Ponte EV, Guimaraes A, Augusto Filho A. Hospitalizations for asthma: impact of a program for the control of asthma and allergic rhinitis in Feira de Santana, Brazil. J Bras Pneumol. 2009;35(8):723–9.PubMed
39.
Charlton I, Charlton G, Broomfield J, Campbell M. An evaluation of a nurse-run asthma clinic in general practice using an attitudes and morbidity questionnaire. Fam Pract. 1992;9(2):154–60.PubMed
40.
Charlton I, Charlton G, Broomfield J, Mullee MA. Audit of the effect of a nurse run asthma clinic on workload and patient morbidity in a general practice. Br J Gen Pract. 1991;41(347):227–31.PubMedPubMedCentral
41.
D’Souza W, Burgess C, Ayson M, Crane J, Pearce N, Beasley R. Trial of a “credit card” asthma self-management plan in a high-risk group of patients with asthma. J Allergy Clin Immunol. 1996;97(5):1085–92.PubMed
42.
D’Souza W, Crane J, Burgess C, Te Karu H, Fox C, Harper M, et al. Community-based asthma care: trial of a “credit card” asthma self-management plan. Eur Respir J. 1994;7(7):1260–5.PubMed
43.
Emmerton L, Shaw J, Kheir N. Asthma management by New Zealand pharmacists: a pharmaceutical care demonstration project. J Clin Pharm Ther. 2003;28(5):395–402.PubMed
44.
Franco R, Nascimento HF, Cruz AA, Santos AC, Souza-Machado C, Ponte EV, et al. The economic impact of severe asthma to low-income families. Allergy. 2009;64(3):478–83.PubMed
45.
Franco R, Santos AC, do Nascimento HF, Souza-Machado C, Ponte E, Souza-Machado A, et al. Cost-effectiveness analysis of a state funded programme for control of severe asthma. BMC Public Health. 2007;7:82.PubMedPubMedCentral
46.
Hertzman PA, Kelly HW, Coultas D. Chronic illness care in Russia: a pilot project to improve asthma care in a “closed city”. Chest. 2005;127(3):861–5.PubMed
47.
Ignacio-Garcia JM, Pinto-Tenorio M, Chocron-Giraldez MJ, Cabello-Rueda F, Lopez-Cozar Gil AI, Ignacio-Garcia JM, et al. Benefits at 3 yrs of an asthma education programme coupled with regular reinforcement. Eur Respir J. 2002;20(5):1095–101.PubMed
48.
Licskai C, Sands T, Ong M, Paolatto L, Nicoletti I. Using a knowledge translation framework to implement asthma clinical practice guidelines in primary care. Int J Qual Health Care. 2012;24(5):538–46.PubMedPubMedCentral
49.
Lind A, Kaplan L, Berg GD. Evaluation of an asthma disease management program in a Medicaid population. Dis Manag Health Out. 2006;14(3):151–61.
50.
Lindberg M, Ahlner J, Moller M, Ekstrom T. Asthma nurse practice--a resource-effective approach in asthma management. Respir Med. 1999;93(8):584–8.PubMed
51.
Maljanian R, Wolf S, Goethe J, Hernandez P, Horowitz S. An inner-city asthma disease management initiative: results of an outcomes evaluation. Dis Manag Health Out. 1999;5(5):285–93.
52.
Mangiapane S, Schulz M, Muhlig S, Ihle P, Schubert I, Waldmann HC. Community pharmacy-based pharmaceutical care for asthma patients. Ann Pharmacother. 2005;39(11):1817–22.PubMed
53.
Narhi U, Airaksinen M, Tanskanen P, Enlund H. The effects of a pharmacy-based intervention on the knowledge and attitudes of asthma patients. Patient Educ Couns. 2001;43(2):171–7.PubMed
54.
Patel PH, Welsh C, Foggs MB. Improved asthma outcomes using a coordinated care approach in a large medical group. Dis Manag. 2004;7(2):102–11.PubMed
55.
Pauley TR, Magee MJ, Cury JD. Pharmacist-managed, physician-directed asthma management program reduces emergency department visits. Ann Pharmacother. 1995;29(1):5–9.PubMed
56.
Ponte E, Franco RA, Souza-Machado A, Souza-Machado C, Cruz AA. Impact that a program to control severe asthma has on the use of Unified Health System resources in Brazil. J Bras Pneumol. 2007;33(1):15–9.PubMed
57.
Steuten L, Vrijhoef B, Van Merode F, Wesseling GJ, Spreeuwenberg C. Evaluation of a regional disease management programme for patients with asthma or chronic obstructive pulmonary disease. Int J Qual Health Care. 2006;18(6):429–36.PubMed
58.
To T, Cicutto L, Degani N, McLimont S, Beyene J. Can a community evidence-based asthma care program improve clinical outcomes? A longitudinal study. Med Care. 2008;46(12):1257–66.PubMed
59.
Tschopp JM, Frey JG, Pernet R, Burrus C, Jordan B, Morin A, et al. Bronchial asthma and self-management education: implementation of guidelines by an interdisciplinary programme in health network. Swiss Med Wkly. 2002;132(7-8):92–7.PubMed
60.
Boonsawat W, Eiadprapan W. Successful of the National Asthma Program using the Easy Asthma Clinic Model to improve Asthma Management in Thailand. Respirology. 2013. doi:10.​1111/​resp.​12184_​12.
61.
Fireman B, Bartlett J, Selby J. Can disease management reduce health care costs by improving quality? Health Aff (Millwood). 2004;23(6):63–75.
62.
Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M, et al. A 10 year asthma programme in Finland: major change for the better. Thorax. 2006;61(8):663–70.PubMedPubMedCentral
63.
Kauppi P, Linna M, Martikainen J, Makela MJ, Haahtela T. Follow-up of the Finnish Asthma Programme 2000-2010: reduction of hospital burden needs risk group rethinking. Thorax. 2013;68(3):292–3.PubMed
64.
Mehring M, Donnachie E, Mutschler R, Hofmann F, Keller M, Schneider A. Disease management programs for patients with asthma in Germany: a longitudinal population-based study. Respir Care. 2013;58(7):1170–7.PubMed
65.
Souza-Machado C, Souza-Machado A, Franco R, Ponte EV, Barreto ML, Rodrigues LC, et al. Rapid reduction in hospitalisations after an intervention to manage severe asthma. Eur Respir J. 2010;35(3):515–21.PubMed
66.
Carmo TA, Andrade SM, Cerci Neto A. Evaluation of an asthma control program in family health units. Cad Saude Publica. 2011;27(1):162–72.PubMed
67.
Lindberg M, Ahlner J, Ekstrom T, Jonsson D, Moller M. Asthma nurse practice improves outcomes and reduces costs in primary health care. Scand J Caring Sci. 2002;16(1):73–8.PubMed
68.
Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax. 2007;62(6):496–502.PubMedPubMedCentral
69.
Cambach W, Chadwick-Straver RV, Wagenaar RC, van Keimpema AR, Kemper HC. The effects of a community-based pulmonary rehabilitation programme on exercise tolerance and quality of life: a randomized controlled trial. Eur Respir J. 1997;10(1):104–13.PubMed
70.
Castro M, Zimmermann NA, Crocker S, Bradley J, Leven C, Schechtman KB. Asthma intervention program prevents readmissions in high healthcare users. Am J Respir Crit Care Med. 2003;168(9):1095–9.PubMed
71.
Charrois TL, Newman SC, Senthilselvan A, Tsuyuki RT. Improving asthma control in the rural setting: The BREATHE (Better Respiratory Education and Asthma Treatment in Hinton and Edson) study. Can Pharm J (Ott). 2006;139(4):44–50.
72.
Couturaud F, Proust A, Frachon I, Dewitte JD, Oger E, Quiot JJ, et al. Education and self-management: a one-year randomized trial in stable adult asthmatic patients. J Asthma. 2002;39(6):493–500.PubMed
73.
Galbreath AD, Smith B, Wood PR, Inscore S, Forkner E, Vazquez M, et al. Assessing the value of disease management: Impact of 2 disease management strategies in an underserved asthma population. Ann Allergy Asthma Immunol. 2008;101(6):599–607.PubMed
74.
Huang TT, Li YT, Wang CH. Individualized programme to promote self-care among older adults with asthma: randomized controlled trial. J Adv Nurs. 2009;65(2):348–58.PubMed
75.
Kokubu F, Nakajima S, Ito K, Makino S, Kitamura S, Fukuchi Y, et al. Hospitalization reduction by an asthma tele-medicine system. Arerugi. 2000;49(1):19–31.PubMed
76.
Martin MA, Catrambone CD, Kee RA, Evans AT, Sharp LK, Lyttle C, et al. Improving asthma self-efficacy: developing and testing a pilot community-based asthma intervention for African American adults. J Allergy Clin Immunol. 2009;123(1):153–9.PubMedPubMedCentral
77.
Mayo PH, Richman J, Harris HW. Results of a program to reduce admissions for adult asthma [see comment]. Ann Intern Med. 1990;112(11):864–71.PubMed
78.
McLean W, Gillis J, Waller R. The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Can Respir J. 2003;10(4):195–202.PubMed
79.
Petro W, Schulenburg JM, Greiner W, Weithase J, Schulke A, Metzdorf N. Efficacy of a disease management programme in asthma. Pneumologie. 2005;59(2):101–7.PubMed
80.
Schatz M, Gibbons C, Nelle C, Harden K, Zeiger RS. Impact of a care manager on the outcomes of higher risk asthmatic patients: a randomized controlled trial. J Asthma. 2006;43(3):225–9.PubMed
81.
Smith JR, Mildenhall S, Noble MJ, Shepstone L, Koutantji M, Mugford M, et al. The Coping with Asthma Study: a randomised controlled trial of a home based, nurse led psychoeducational intervention for adults at risk of adverse asthma outcomes. Thorax. 2005;60(12):1003–11.PubMedPubMedCentral
82.
Wilson SR, Strub P, Buist AS, Knowles SB, Lavori PW, Lapidus J, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med. 2010;181(6):566–77.PubMed
83.
Herborg H, Soendergaard B, Froekjaer B, Fonnesbaek L, Jorgensen T, Hepler CD, et al. Improving drug therapy for patients with asthma--part 1: Patient outcomes. J Am Pharm Assoc (Wash). 2001;41(4):539–50.
84.
Herborg H, Soendergaard B, Jorgensen T, Fonnesbaek L, Hepler CD, Holst H, et al. Improving drug therapy for patients with asthma-part 2: Use of antiasthma medications. J Am Pharm Assoc (Wash). 2001;41(4):551–9.
85.
Feifer RA, Verbrugge RR, Khalid M, Levin R, O’Keefe GB, Aubert RE. Improvements in asthma pharmacotherapy and self-management: an example of a population-based disease management program. Dis Manag Health Out. 2004;12(2):93–102.
86.
Landon BE, Hicks LS, O’Malley AJ, Lieu TA, Keegan T, McNeil BJ, et al. Improving the management of chronic disease at community health centers. N Engl J Med. 2007;356(9):921–34.PubMed
87.
Weng HC. Impacts of a government-sponsored outpatient-based disease management program for patients with asthma: a preliminary analysis of national data from Taiwan. Dis Manag. 2005;8(1):48–58.PubMed
88.
Windt R, Glaeske G. Effects of a German asthma disease management program using sickness fund claims data. J Asthma. 2010;47(6):674–9.PubMed
89.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.PubMedPubMedCentral
90.
Herland K, Akselsen J-P, Skjønsberg OH, Bjermer L. How representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease? Respir Med. 2005;99(1):11–9.PubMed
91.
Price D, Brusselle G, Roche N, Freeman D, Chisholm A. Real-world research and its importance in respiratory medicine. Breathe. 2015;11(1):26–38.PubMedPubMedCentral
92.
Rockers PC, Rottingen JA, Shemilt I, Tugwell P, Barnighausen T. Inclusion of quasi-experimental studies in systematic reviews of health systems research. Health Policy. 2015;119(4):511–21.PubMed
93.
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655.PubMedPubMedCentral
94.
Rockers PC, Feigl AB, Rottingen JA, Fretheim A, de Ferranti D, Lavis JN, et al. Study-design selection criteria in systematic reviews of effectiveness of health systems interventions and reforms: A meta-review. Health Policy. 2012;104(3):206–14.PubMed
95.
Schünemann HJ, Tugwell P, Reeves BC, Akl EA, Santesso N, Spencer FA, et al. Non-randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions. Res Synth Methods. 2013;4(1):49–62.PubMed
96.
Kunz R, Oxman AD. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ. 1998;317(7167):1185–90.PubMedPubMedCentral
97.
Peinemann F, Tushabe DA, Kleijnen J. Using multiple types of studies in systematic reviews of health care interventions--a systematic review. PLoS One. 2013;8(12):e85035.PubMedPubMedCentral
98.
MacLehose RR, Reeves BC, Harvey IM, Sheldon TA, Russell IT, Black AM. A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies. Health Technol Assess. 2000;4(34):1–154.PubMed
99.
Oliver S, Bagnall AM, Thomas J, Shepherd J, Sowden A, White I, et al. Randomised controlled trials for policy interventions: a review of reviews and meta-regression. Health Technol Assess. 2010;14(16):1–165. iii.PubMed
100.
Reeves BC, Higgins JPT, Ramsay C, Shea B, Tugwell P, Wells GA. An introduction to methodological issues when including non-randomised studies in systematic reviews on the effects of interventions. Res Synth Methods. 2013;4(1):1–11.PubMed
101.
Methodology Committee of the Patient-Centered Outcomes Research I. Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. JAMA. 2012;307(15):1636–40.
102.
Maciejewski ML, Chen SY, Au DH. Adult asthma disease management: an analysis of studies, approaches, outcomes, and methods. Respir Care. 2009;54(7):878–86.PubMed
103.
Lemmens KM, Nieboer AP, Huijsman R. A systematic review of integrated use of disease-management interventions in asthma and COPD. Respir Med. 2009;103(5):670–91.PubMed
104.
Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, et al. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000;321(7262):694–6.PubMedPubMedCentral
105.
Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F, et al. Designing and evaluating complex interventions to improve health care. BMJ. 2007;334(7591):455–9.PubMedPubMedCentral
106.
107.
Mohler R, Kopke S, Meyer G. Criteria for reporting the development and evaluation of complex interventions in healthcare: revised guideline (CReDECI 2). Trials. 2015;16:204.PubMedPubMedCentral
108.
109.
Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014. doi:10.​1136/​bmj.​g1687.PubMedCentral
110.
Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf. 2015. doi:10.​1136/​bmjqs-2015-004411.
111.
Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010. doi:10.​1136/​bmj.​c869.
112.
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology. 2007;18(6):800–4.
Metadata
Title
Adding non-randomised studies to a Cochrane review brings complementary information for healthcare stakeholders: an augmented systematic review and meta-analysis
Authors
Chantal Arditi
Bernard Burnand
Isabelle Peytremann-Bridevaux
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2016
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-016-1816-5

Other articles of this Issue 1/2016

BMC Health Services Research 1/2016 Go to the issue

Research article

Who benefited from the New Rural Cooperative Medical System in China? A case study on Anhui Province

Research article

Co-creation of an ICT-supported cancer rehabilitation application for resected lung cancer survivors: design and evaluation

Research article

Managing Matajoosh: determinants of first Nations’ cancer care decisions

Research article

Budget impact of secondary hyperparathyroidism treatment in chronic kidney disease in an Ecuadorian social security hospital

Research article

The household economic burden for acute coronary syndrome survivors in Australia

Research article

Compliance with birth dose of Hepatitis B vaccine in high endemic and hard to reach areas in the Colombian amazon: results from a vaccination survey